Who to call at Hikma Pharmaceuticals, and when

Fundz watches for the moments Hikma Pharmaceuticals starts buying, and tells you who to reach.

An alert the day Hikma Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Hikma Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hikma Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Hikma Pharmaceuticals and IFC Sign $250 Million Financing Agreement to Enhance Medicine Access in MENA.

Jul 15, 2025

Contract Type

partnership

OhioManufacturingBiotechnologyHealth CarePharmaceutical

Description

Hikma Pharmaceuticals PLC and the International Finance Corporation have signed a $250 million financing agreement aimed at improving access to medicines in the MENA region. This partnership has a history of 40 years and reinforces IFC's commitment to support Hikma's operations and local production of medicines.

Company Information

Company

Hikma Pharmaceuticals

Location

Ohio, United States

About

Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. The company specializes in the manufacturing of complex generics, particularly sterile injectables, aimed at addressing the growing demand for oncology and chronic-care drugs. With a significant expansion in Ohio, Hikma aims to solidify its position by leveraging AI-driven private markets for funding. The company is focused on producing over 12 billion doses annually by 2030.